Investigational HCV regimen highly effective in Japanese genotype-1 patients

[HFIAdmin]

The newly submitted NDA from Abbvie has released another study result, this time, on Japanese HCV genotype-1 patients. "Overall, 105 of 106 patients (99%) without cirrhosis and without the Y93H variant achieved SVR12."

bit.ly/2k10Lan